This report provides a preview of clinical trials that are planned to be initiated and projected to be completed in 2023.
The clinical trials data used for these analyses were extracted from GlobalData’s Clinical Trials Database. The data included planned clinical trials with a start date from January 1 to December 31, 2023, captured in the database as of December 15, 2022. The planned trials were analyzed and segmented by phase, single versus multinational trials, geography, sponsor type (industry versus non-industry), therapy area, indication, top sponsors, drug type, and DCT use. Clinical trials with an ongoing or planned status with an end date between January 1 and December 31, 2023, were also examined. The trials that are estimated to be completed in 2023 were split by phase, status, indication, sponsor type, top sponsors, geography and DCT use. In this report, a small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, Phase II, Phase III, and Phase IV trials, respectively.
Reasons to Buy
Understand the planned trials landscape and trends for 2023
Provide early insight for studies expected to be completed in 2023
The 2023 trends of DCTs in both planned trials and trials to be completed
Table of Contents
Tables and Figures
• List of Figures
Clinical Trials Planned to Initiate in 2023
Clinical Trials Estimated to Complete in 2023
List of Figures
List of Figures
Figures 1 and 2: Planned Clinical Trials, by Phase and Sponsor Type
Figure 3: Planned Clinical Trials Top Industry Sponsors, by Phase
Figure 4: Planned Clinical Trials Top Non-Industry Sponsors, by Phase
Figure 5: Planned Clinical Trials Single Country or Multinational, by Sponsor Type and Phase
Figure 6: Planned Clinical Trials Regions, by Phase
Figure 7: Planned Clinical Trials Regions, by Phase and Distribution
Figure 8: Planned Clinical Trials Country, by Phase
Figure 9: Planned Clinical Trials Country, by Phase and Distribution
Figures 10 and 11: Planned Clinical Trials Primary Intervention Molecule Type, by Phase and Distribution
Figure 12: Planned Clinical Trials Top Therapy Areas, by Phase
Figure 13: Planned Clinical Trials Top Therapy Areas, by Phase and Distribution
Figure 14: Planned Clinical Trials Top Indications, by Phase
Figure 15: Planned Clinical Trials Top Indications, by Phase and Distribution
Figures 16 and 17: Total Planned Clinical DCT Trials, by Therapeutic Area
Figure 18: Estimated to Complete Clinical Trials, by Phase
Figures 19 and 20: Estimated to Complete Clinical Trials by Status, by Phase and Phase Distribution
Figure 21: Estimated to Complete Clinical Trials, by Sponsor Type and Phase
Figure 22: Estimated to Complete Clinical Trials, by Top Industry Sponsor and Phase
Figure 23: Estimated to Complete Clinical Trials, by Top Non-Industry Sponsor and Phase
Figure 24: Estimated to Complete Single Country or Multinational Clinical Trials, by Region
Figure 25: Estimated to Complete Clinical Trials, by Country
Figure 26: Estimated to Complete Clinical Trials, by Therapy Area and Phase
Figure 27: Estimated to Complete Clinical Trials, by Indication and Phase
Figures 28 and 29: Total Estimated to Complete DCT Clinical Trials, by Region and Single Country or Multinational
Figure 30: Estimated to Complete DCT Clinical Trials, by Therapy Area and Phase
Tel +44 (0) 20 7947 2960
Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.